Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024 - PubMed
3 days ago
- #Real-world evidence
- #Healthcare economics
- #COVID-19 vaccines
- Seasonal COVID-19 vaccination in routine care significantly reduced rates of long COVID (RR: 0.43), respiratory infections (RR: 0.91), and COVID-19-related hospitalizations (RR: 0.41) during the early endemic phase in Germany.
- All-cause mortality was 25% lower among vaccinated individuals (HR: 0.76), with healthcare cost savings, including EUR 1 million from fewer hospitalizations and EUR 1.3 million from reduced sick leave.
- The study, based on over 3 million individuals from statutory health insurance data, supports continued implementation of national COVID-19 vaccination recommendations due to substantial clinical and economic benefits.